Ainos Inc 2026年季度报告

FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the quarterly period ended March 31, 2026 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the transition period from____to____ Commission File No. 001-41461 AINOS, INC.(Exact name of registrant as specified in its charter) TEXAS75-1974352(State or other jurisdiction ofincorporation or organization)(IRS EmployerIdentification No.) 3050 Post Oak Blvd, Suite 510-T80, Houston, TX 77056 (281)898-6586(Address and telephone number, including area code, of registrant’s principal executive offices) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.☒Yes☐No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files).☒Yes☐No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☒Emerging growth company☐ Large accelerated filer☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)☐Yes☒No As of May 13, 2026, there were issued and outstanding 8,524,542 shares of the registrant’s common stock, par value $0.01, which isthe only class of common or voting stock of the registrant. AINOS, INC.INDEX PAGENO.PART I:FINANCIAL INFORMATION3ITEM 1.Financial Statements3Condensed Consolidated Balance Sheets – March 31, 2026 (unaudited) and December 31, 20253Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2026 and 2025(unaudited)4Condensed Consolidated Statements of Comprehensive Loss – Three Months Ended March 31, 2026 and 2025(unaudited)5Condensed Consolidated Statements of Stockholders’ Equity– Three Months Ended March 31, 2026 and 2025(unaudited)6Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2026 and 2025(unaudited)7Notes to Condensed Consolidated Financial Statements (unaudited)8ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations19ITEM 3.Quantitative and Qualitative Disclosures About Market Risk24ITEM 4.Controls and Procedures24PART II:OTHER INFORMATION25ITEM 1.Legal Proceedings25ITEM 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities26ITEM 3.Defaults Upon Senior Securities26ITEM 4.Mine Safety Disclosures26ITEM 5.Other Information26ITEM 6.Exhibits27Signatures282 PART I - FINANCIAL INFORMATION Ainos, Inc.Condensed Consolidated Balance Sheets Ainos, Inc.Condensed Consolidated Statements of Operations(Unaudited) Ainos, Inc.Condensed Consolidated Statements of Comprehensive Loss(Unaudited) Ainos, Inc.Condensed Consolidated Statements of Stockholders’ EquityFor the three months ended March 31, 2026 and 2025(Unaudited) Ainos, Inc.Condensed Consolidated Statements of Cash Flows(Unaudited) Ainos, Inc.Notes to Condensed Consolidated Financial Statements(Unaudited) 1. Description of Business Organization and Business Ainos, Inc. (the “Company”) was incorporated in the State of Texas in 1984. The Company is a dual-platform company engaged in thedevelopment of artificial intelligence-enabled olfactory sensing technologies, which we refer to as “SmellTech” or “Smell AI”, andrelated applications, as well as the development of immune therapeutics. Our core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietaryartificial intelligence models, which we refer to as a smell language model (“SLM”), to digitize scent and volatile organic compound(“VOC”) signals into Smell ID, a machine-readable data format. AI Nose is initially developed in healthcare-related settings, includingpoint-of-care testing (“POCT”). These early healthcare applications shaped the platform’s sensor architecture, data models, and systemcalibration. Building